<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/41A6F529-3374-4F2A-8350-29C571A8C235"><gtr:id>41A6F529-3374-4F2A-8350-29C571A8C235</gtr:id><gtr:name>European Commission (EC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/19AE1042-BEA6-43F9-931B-07741962E417"><gtr:id>19AE1042-BEA6-43F9-931B-07741962E417</gtr:id><gtr:name>Central Manchester University Hospitals NHS Foundation Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A19A6372-A1A2-4F0D-AED7-7110E0A05C9B"><gtr:id>A19A6372-A1A2-4F0D-AED7-7110E0A05C9B</gtr:id><gtr:name>Sheffield Teaching Hospitals NHS Foundation Trust</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Reproduction and Endocrinology</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/41A6F529-3374-4F2A-8350-29C571A8C235"><gtr:id>41A6F529-3374-4F2A-8350-29C571A8C235</gtr:id><gtr:name>European Commission (EC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/19AE1042-BEA6-43F9-931B-07741962E417"><gtr:id>19AE1042-BEA6-43F9-931B-07741962E417</gtr:id><gtr:name>Central Manchester University Hospitals NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A19A6372-A1A2-4F0D-AED7-7110E0A05C9B"><gtr:id>A19A6372-A1A2-4F0D-AED7-7110E0A05C9B</gtr:id><gtr:name>Sheffield Teaching Hospitals NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/3611393C-B14F-4035-B03B-9F07C2EAAD6F"><gtr:id>3611393C-B14F-4035-B03B-9F07C2EAAD6F</gtr:id><gtr:firstName>Gillian</gtr:firstName><gtr:surname>Bates</gtr:surname><gtr:orcidId>0000-0002-4041-6305</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4794DBFA-A373-4FBB-BEBA-19464666D305"><gtr:id>4794DBFA-A373-4FBB-BEBA-19464666D305</gtr:id><gtr:firstName>Josie</gtr:firstName><gtr:surname>McConnell</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/7B34929B-589F-4563-B96F-13470FC214BA"><gtr:id>7B34929B-589F-4563-B96F-13470FC214BA</gtr:id><gtr:firstName>Christine</gtr:firstName><gtr:otherNames>L</gtr:otherNames><gtr:surname>Mummery</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/133906A5-01B5-4F0D-9A85-0D17BE399023"><gtr:id>133906A5-01B5-4F0D-9A85-0D17BE399023</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:surname>Minger</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D68A5444-F384-4F91-A123-AF9D11ADA89D"><gtr:id>D68A5444-F384-4F91-A123-AF9D11ADA89D</gtr:id><gtr:firstName>DUSKO</gtr:firstName><gtr:surname>ILIC</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0701172"><gtr:id>655AAF95-95B6-45D5-837B-C4B85C010BB8</gtr:id><gtr:title>Generation of human embryonic stem cell lines with clinically relevant mutations</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0701172</gtr:grantReference><gtr:abstractText>Human embryonic stem (hES) cells can be isolated from early (4-8 day old) developing embryos which have been grown in the laboratory as part of, or surplus to some kinds of IVF treatment. Under certain conditions, these can be made to develop into different kinds of cells, such as nerve, or pancreatic cells which it is hoped in the future, may be useful in treating degenerative diseases such as Parkinson s disease and diabetes, or in spinal injuries by replacing the diseased or damaged cells with healthy hES cells which have been grown in the laboratory. However in addition to this potential use in therapy, the study of stem cells in the laboratory which contain clinically relevant genetic mutations - ?diseases in a dish? - may give us insights in to the early developmental mechanisms in certain genetic disorders.
With the Assisted Conception Unit (ACU) at Guy s we have been using surplus embryos donated by patients undergoing preimplantation genetic diagnosis treatment (PGD). PGD is offered to couples who carry a serious genetic disorder where the embryos are tested for the disorder prior to implantation in order to prevent transmission of diseases such as Huntington s disease, Duchenne muscular dystrophy, and spinal muscular atrophy. Embryos that are found to be free of disorder can be transferrred back to the patient s womb, or frozen for their later use. Those which will develop the genetic disorder or are of uncertain status and should not be placed back into the woman?s womb have been used to generate stem cell lines which contain the specific genetic mutation, and will be useful in understanding more about these diseases, and developing new treatments for them. All stem cell derivation from embryos is strictly monitored in the UK and requires a licence from the Human Fertilisation and Embryology Authority. It is a condition of licence that samples of any suitable stem cell lines developed must sent to the UK Stem Cell Bank from where they are made freely available to research scientists in the UK and abroad through the MRC Stem Cell Steering Committee.</gtr:abstractText><gtr:technicalSummary>The development and support of the UK stem cell bank at NIBSC is a clear signal of the UK?s commitment to support both local and international research on stem cells, and to the development of lines suitable for research and clinical use. Besides the need to generate human embryonic stem (hES) cell lines for therapeutic use, there is the opportunity to use hES cell lines as an in vitro alternative to animal experiments for studying cell-cell or developing organ interactions, and the effect of pharmacological agents. Such an approach is likely to be especially useful in lines generated from embryos shown to contain specific clinically relevant genetic mutations following PGD. This strategy is predicated on the assumption that disease-carrying hESCs will differentiate faithfully and reliably into relevant differentiated cells that are functionally competent. This application seeks to test the hypothesis that disease-carrying hESCs reliably express the disease phenotype in neuroprogenitors and muscle cells after hESC differentiation in vitro. Being the largest and most successful PGD unit in the UK, and the first internationally to establish and characterise a line carrying the common deltaF508 mutation, as well as two lines containing HD expansions, we are in a leadership position to both establish and characterise additional disease carrying hESCs. It is our intention, using morphological, immunological, and molecular markers, to explore the development of neurones in stem cells with HD expansions, cardiomyocyte development and physiology in Duchenne muscular dystrophy (DMD) and neurones and myocytes in spinal muscular atrophy (SMA), which are among our most common diagnostic requests. In addition to these, we are likely to be able to generate lines with other clinically relevant mutations, which will be an invaluable research resource to others investigators which we will make available internationally through the UK Stem Cell Bank (UKSCB).</gtr:technicalSummary><gtr:fund><gtr:end>2012-07-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-01-05</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>600000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Commission (EC)</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:department>EC FP6 Collaborative Projects</gtr:department><gtr:description>hESReg European Stem Cell Registry</gtr:description><gtr:id>AE382769-9843-42F5-95A7-4FB9C8C54A88</gtr:id><gtr:impact>First European wide stem cell registry of Embryonic and iPS stem cells http://www.hescreg.eu/</gtr:impact><gtr:partnerContribution>Contribute to data in registry Braude is member of scientific advisory committee</gtr:partnerContribution><gtr:piContribution>Member of Scientific Advisory board and contributor to Bank registry</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sheffield Teaching Hospitals NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Assisted Conception Unit</gtr:department><gtr:description>hESCCO (Human Embryonic Stem Cell Coordinators)</gtr:description><gtr:id>7565CE43-A346-4635-8305-358369E1FD37</gtr:id><gtr:impact>A group patient information and consent form has been produced in the past to give patients uniform information. The group has established a website in which to communicate. We have also produced a joint publication - Ref 18154466.</gtr:impact><gtr:partnerContribution>Knowledge transfer and experience.Knowledge transfer and experience</gtr:partnerContribution><gtr:piContribution>The hESCCO group was formed before this grant was approved. Therefore any collaborations made had already been established. With regard to this, we organised group meetings and established lines of communication between parties.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Central Manchester University Hospitals NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>St Mary's Hospital for Women and Children Manchester, Department of Obstetrics and Gynaecology</gtr:department><gtr:description>hESCCO (Human Embryonic Stem Cell Coordinators)</gtr:description><gtr:id>D29B5D8B-5868-4317-BB81-040DDA92C414</gtr:id><gtr:impact>A group patient information and consent form has been produced in the past to give patients uniform information. The group has established a website in which to communicate. We have also produced a joint publication - Ref 18154466.</gtr:impact><gtr:partnerContribution>Knowledge transfer and experience.Knowledge transfer and experience</gtr:partnerContribution><gtr:piContribution>The hESCCO group was formed before this grant was approved. Therefore any collaborations made had already been established. With regard to this, we organised group meetings and established lines of communication between parties.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Workshop on stem cell &amp; cancer research</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>488E5035-79F5-43E4-9FC8-13FA0CE59F40</gtr:id><gtr:impact>CONFERENCE: King's College London and national Yang-Ming University, Taiwan, workshop on stem cell &amp;amp; cancer research
DATE: 17-19 Sep 2012
ORGANIZER: www.kcl.ac.uk
TITLE: Pluripotent stem cells at King's
AUTHORS: Dusko Ilic
LOCATION: King's College London, London, UK

networking, promotion of our research and resources</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Clinical embryologist meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>88DC420D-17F9-4DDF-BCFD-5EA91E44B5FC</gtr:id><gtr:impact>ACE meeting Edinburgh (Jan 09). &amp;quot;Implications of donating embryos for stem cell research&amp;quot;

None</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Embryologist national meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>7CBE060C-64BA-4F43-B574-1F1DBA39EBB3</gtr:id><gtr:impact>Jan 09 - &amp;quot;Implications of donating embryos for stem cell research, ACE meeting, Edinburgh

Information for UK embryologists about stem cell research; need, and practical and ethical implications</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar - London</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>5480ED75-824E-4B3D-BE2B-EE72493D229C</gtr:id><gtr:impact>Presented update of research results to embryologists and research nurses from collaborating units

Continuing acquisition of research embryos from collaborating units</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009,2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Stem cells and regenerative medicine seminars, Ljubljana, Slovenia</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>39226141-4E08-4BFA-B692-CCAC5B948A54</gtr:id><gtr:impact>About 30 undergraduate students and 10 faculties attanded a series of 6 lectures on stem cells and regeneratiev medicine

University of Ljubljana, Faculty of Pharmacy is currently applying for a Public Tender for cofinancing activities in years 2012-15, which stimulate openness of Slovenian Higher education into international environment released by Ministry of Education, Science, Culture and Sport - financed by the European Union and the Republic of Slovenia. 

D Ilic has been invited to participate as a guest expert and leader of international Workshop in Stem cells and Regenerative Mediince within the proposed project if being selected at the public tender.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>DKF Research Conference, Bern, Switzerland</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>529ABC9B-6262-4FDC-ACCA-9699E300ADCF</gtr:id><gtr:impact>More than 100 academic researchers attanded the lecture

Intense Q&amp;amp;A session lasting more than 30 minutes</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Infertility nurses meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>59819934-8E71-4E7E-AE6F-A7E33744B629</gtr:id><gtr:impact>Glenda Cornwell Sept 07 - &amp;quot;Embryonic Stem Cell Research: The nurses role&amp;quot; National Fertility Nurse annual conference

Informing nurses involved in assisted conception units about need and use of surplus embryos for stem cell research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>video clip on BBC website</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>07258B9B-3E1C-4CFD-8BC9-88611F6A2135</gtr:id><gtr:impact>SERIES: Health Explained
TITLE: How to make stem cells
DATE OF PUBLICATION: 21 Jun 2012
URL: www.bbc.co.uk/news/health-18496355

promoting our research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford May Music</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>D826E0D6-E80D-4013-90D6-C7AA1707F6A5</gtr:id><gtr:impact>Presentation on 'Embryonic stem cells - strings attached' - part of science and music programme held in oxford for lay audience booking ahead and attendiing for oncerts

Difficult to assess other than requests for other similar talks for schools.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Bioethics study day ~London</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>0644A16C-1989-4DD8-909C-3C80C0D1F7BB</gtr:id><gtr:impact>Glenda Cornwell &amp;amp; Emma Stephenson Churches Together in England Bioethics Discussion Day: Stem Cells - What are they and why might they be useful?

Advising and discussing with church ideas of stem cell research and need for use of human embryos</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Lecture Oxford</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>B4A730E3-F097-40C9-9D00-30F02CA2490D</gtr:id><gtr:impact>May 2009 - Oxford May Music series- Human embryonic stem cells; Strings attached. General audience in science and music series.

Increased awareness of achievements of stem cell research and need for use of eggs and embryos</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>484420</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant (G0801061)</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>AB8D1DF5-B221-4C3E-AFFF-5732A17EA658</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant (G0701172)</gtr:description><gtr:end>2012-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>3007C536-AF18-417B-B80F-7D5B361388C4</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>800000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Welcome biomedical ethics strategic award</gtr:description><gtr:end>2014-04-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>38AF0FBA-3BC3-4653-B82D-04DBE0FBF988</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Refurbishment of IVF lab and stem cell laboratories</gtr:description><gtr:end>2008-12-02</gtr:end><gtr:fundingOrg>King's College London (KCL)</gtr:fundingOrg><gtr:id>C454CD50-CDDA-4385-BDFF-59E904CA9E54</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Progress Educational Trust Advisory Board</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F0E7CE3A-42E1-4118-A232-7AB375736FB8</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Route Map for Stem Cell Regulation</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>752BB942-F755-4DFD-84C4-B7408D26C191</gtr:id><gtr:impact>Joint meeting of regulators to simplify processing of stem cell applications through HFEA, HTA, MHRA for clinical application</gtr:impact><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>European human embryonic stem cell registry - hESCreg</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>FECF7B76-A386-4949-B98C-48BFBF824FE2</gtr:id><gtr:impact>Provides information about what lines are available for distribution in Europe, their quality stage and particular characteristics which may be useful in developing lines for therapy</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Advisory Committee on Safety of Cells Tissues and Organs</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>88C3F777-666E-4DD5-9498-43A1DC9E3A53</gtr:id><gtr:impact>Member advising on testing and use of reproductive and stem cell tissues.</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Joint committee on the Human Tissue and Embryos (Draft) Bill</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>190D41FA-3253-447F-A173-7C73D791EC00</gtr:id><gtr:impact>Contributed to the demise of joint HFEA/HTA ALB to be called RATE. Remained as separate bodies and stem cell derivation remained under HFEA</gtr:impact><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>ESHRE PGD Guideline</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:guidelineTitle>ESHRE guidelines on practice of PGD</gtr:guidelineTitle><gtr:id>0B008EA8-2B61-43B2-B250-B8A3305CC33E</gtr:id><gtr:impact>Revision of Guideline to influence standards and practice of preimplantation genetic diagnosis and preimplantation genetic screening which will form the basis of other documents and compliance with EU directives</gtr:impact><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have derived 9 lines from normal embryos cryopreserved in-house or from one of the ten collaborating IVF units (HFEA licence R0133).</gtr:description><gtr:id>EF9EF568-69E9-4C9D-8A34-8889C7A8D577</gtr:id><gtr:impact>The cell lines are either submitted or in process of submission to UKSCB. They will be available to researchers worldwide.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Reseearch grade normal hES cel lines</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have so far derived 22 lines carrying clinically relevant genetic mutations derived from affected embryos following preimplantation genetic diagnosis (PGD) (HFEA licence R0075) which includes cystic fibrosis (4 lines), Huntington's disease (7 lines), myotonic dystrophy type 1 (1 line), neurofibromatosis type 1 (2 lines), spinal muscular atrophy type 1 (1 line), Von Hippel-Lindau cancer syndrome (3 lines), ?-thalassemia (2 line), Wiskott-Aldrich syndrome and cystic fibrosis carrer (1 line), and Turner syndrome (1 line).</gtr:description><gtr:id>CDB37906-91D7-4DC5-AF54-0EA324263A60</gtr:id><gtr:impact>The cells are or will be deposited in the UK Stem Cell Bank. The deposition process is ongoing. The cell lines will be then be available to other researchers. 
The cell lines are also sumnitted to NIH Registry</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Human embryonic stem cell lines with clinically relevant mutations</gtr:title><gtr:type>Cell line</gtr:type><gtr:url>http://www.kcl.ac.uk/medicine/research/divisions/wh/groups/medicine/hescell.aspx</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The sixteen lines of stem cells on the NIH Registry carry genes for various hereditary disorders including Duchenne Muscular Dystrophy, Huntington's disease, cystic fibrosis, and rarer conditions such as Von Hippel-Lindau Syndrome, Wiskott-Aldrich syndrome, spinal muscular atrophy, myotonic dystrophy and neurofibromatosis.</gtr:description><gtr:id>B29E77F3-3562-4C56-86FD-4DDF489506C6</gtr:id><gtr:impact>Sixteen of human embryonic stem (hES) cell lines derived at King's have been approved by the US National Institutes of Health (NIH) and placed on their Stem Cell Registry, making them freely available for federally-funded research in the USA. 
King's is now one of the five biggest providers of disease-specific human embryonic stem cells lines on the NIH Registry, and the largest from the UK. The development is a significant milestone for King's and keeps the university at the forefront of global research into regenerative medicine.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Human embryonic stem cell lines with clinically relevant mutations</gtr:title><gtr:type>Cell line</gtr:type><gtr:url>http://grants.nih.gov/stem_cells/registry/current.htm</gtr:url></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have derived 8 clincal grade hES cell lines from normal embryos cryopreserved in-house or from one of the ten collaborating IVF units (HFEA licence R0133).</gtr:description><gtr:id>F32EAE13-062B-4BA3-8C16-D6E47FF7CD4C</gtr:id><gtr:impact>We are in process of depositing lines in UKSCB. When process is completed, the lines will be available to researchers worldwide.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Clinical grade hES cell lines</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5AE9D68D-8DA0-46FB-9BAA-4B8C8C4B2BFA"><gtr:id>5AE9D68D-8DA0-46FB-9BAA-4B8C8C4B2BFA</gtr:id><gtr:title>Three Huntington's Disease Specific Mutation-Carrying Human Embryonic Stem Cell Lines Have Stable Number of CAG Repeats upon In Vitro Differentiation into Cardiomyocytes.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4a2afc7287a20b64627a082796f08d86"><gtr:id>4a2afc7287a20b64627a082796f08d86</gtr:id><gtr:otherNames>Jacquet L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/614C5805-50A5-4124-80CC-3B603BDAD34B"><gtr:id>614C5805-50A5-4124-80CC-3B603BDAD34B</gtr:id><gtr:title>Human embryonic and induced pluripotent stem cells in clinical trials.</gtr:title><gtr:parentPublicationTitle>British medical bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fab8c9425f975720e58fc9438c517385"><gtr:id>fab8c9425f975720e58fc9438c517385</gtr:id><gtr:otherNames>Ilic D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0007-1420</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DFE6DA83-4017-47D6-BA06-4201ED4583DC"><gtr:id>DFE6DA83-4017-47D6-BA06-4201ED4583DC</gtr:id><gtr:title>Generation of KCL029 research grade human embryonic stem cell line carrying a mutation in WAS gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/05dab0f87d4725838fc83d9f2ff612b9"><gtr:id>05dab0f87d4725838fc83d9f2ff612b9</gtr:id><gtr:otherNames>Miere C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5BE1D3B3-A84E-4FB0-A9A5-9680C713930D"><gtr:id>5BE1D3B3-A84E-4FB0-A9A5-9680C713930D</gtr:id><gtr:title>Generation of KCL027 research grade human embryonic stem cell line carrying a mutation in the HTT gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4a2afc7287a20b64627a082796f08d86"><gtr:id>4a2afc7287a20b64627a082796f08d86</gtr:id><gtr:otherNames>Jacquet L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D4B14D6E-F0A1-4420-A538-6638F083C219"><gtr:id>D4B14D6E-F0A1-4420-A538-6638F083C219</gtr:id><gtr:title>Generation of KCL016 research grade human embryonic stem cell line carrying a mutation in VHL gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/05dab0f87d4725838fc83d9f2ff612b9"><gtr:id>05dab0f87d4725838fc83d9f2ff612b9</gtr:id><gtr:otherNames>Miere C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B2D1C5FB-1260-494B-A414-DAE9F3383280"><gtr:id>B2D1C5FB-1260-494B-A414-DAE9F3383280</gtr:id><gtr:title>Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ec60da3dddaae680a3c7dee1eecb5322"><gtr:id>ec60da3dddaae680a3c7dee1eecb5322</gtr:id><gtr:otherNames>Merkle FT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C16EB32E-0572-423C-BA50-357DCDB5DCFE"><gtr:id>C16EB32E-0572-423C-BA50-357DCDB5DCFE</gtr:id><gtr:title>Human embryonic and induced pluripotent stem cells in clinical trials.</gtr:title><gtr:parentPublicationTitle>British medical bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fab8c9425f975720e58fc9438c517385"><gtr:id>fab8c9425f975720e58fc9438c517385</gtr:id><gtr:otherNames>Ilic D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0007-1420</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C5B8EBD3-16E3-41C8-843F-9D6D40B49846"><gtr:id>C5B8EBD3-16E3-41C8-843F-9D6D40B49846</gtr:id><gtr:title>Preimplantation genetic diagnosis as a source of human embryonic stem cells for disease research and drug discovery.</gtr:title><gtr:parentPublicationTitle>BJOG : an international journal of obstetrics and gynaecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/71cee36ebeeaa4bc610dcbf2411b4d7b"><gtr:id>71cee36ebeeaa4bc610dcbf2411b4d7b</gtr:id><gtr:otherNames>Stephenson EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1470-0328</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/31A73033-D02E-48D2-BEB6-D19D0BB3A066"><gtr:id>31A73033-D02E-48D2-BEB6-D19D0BB3A066</gtr:id><gtr:title>Generation of KCL012 research grade human embryonic stem cell line carrying a mutation in the HTT gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4a2afc7287a20b64627a082796f08d86"><gtr:id>4a2afc7287a20b64627a082796f08d86</gtr:id><gtr:otherNames>Jacquet L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5CB9DF68-A9F5-4435-A020-0C29774B7AD7"><gtr:id>5CB9DF68-A9F5-4435-A020-0C29774B7AD7</gtr:id><gtr:title>Generation of KCL013 research grade human embryonic stem cell line carrying a mutation in the HTT gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4a2afc7287a20b64627a082796f08d86"><gtr:id>4a2afc7287a20b64627a082796f08d86</gtr:id><gtr:otherNames>Jacquet L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6FC4233A-B826-4782-AEE8-F007E31E8A6E"><gtr:id>6FC4233A-B826-4782-AEE8-F007E31E8A6E</gtr:id><gtr:title>ESHRE PGD consortium best practice guidelines for organization of a PGD centre for PGD/preimplantation genetic screening.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/da37d2f1b965b445443b18dc09b1f837"><gtr:id>da37d2f1b965b445443b18dc09b1f837</gtr:id><gtr:otherNames>Harton G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2A7BFC0C-1013-42ED-BBF5-04FA2285E5D5"><gtr:id>2A7BFC0C-1013-42ED-BBF5-04FA2285E5D5</gtr:id><gtr:title>Generation of KCL035 research grade human embryonic stem cell line carrying a mutation in HBB gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5906459f71b6363885611cb5abc8de3a"><gtr:id>5906459f71b6363885611cb5abc8de3a</gtr:id><gtr:otherNames>Hewitson H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/451F822F-1B79-4EE5-8CD4-527E6D2CC1EC"><gtr:id>451F822F-1B79-4EE5-8CD4-527E6D2CC1EC</gtr:id><gtr:title>Derivation and feeder-free propagation of human embryonic stem cells under xeno-free conditions.</gtr:title><gtr:parentPublicationTitle>Cytotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fab8c9425f975720e58fc9438c517385"><gtr:id>fab8c9425f975720e58fc9438c517385</gtr:id><gtr:otherNames>Ilic D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1465-3249</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/584A6D07-43F0-43E5-9B64-0B68CB9E5183"><gtr:id>584A6D07-43F0-43E5-9B64-0B68CB9E5183</gtr:id><gtr:title>Generation of KCL024 research grade human embryonic stem cell line carrying a mutation in NF1 gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5906459f71b6363885611cb5abc8de3a"><gtr:id>5906459f71b6363885611cb5abc8de3a</gtr:id><gtr:otherNames>Hewitson H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AF694CBE-F8FD-4850-B7B1-7251305BCC91"><gtr:id>AF694CBE-F8FD-4850-B7B1-7251305BCC91</gtr:id><gtr:title>Induced Pluripotent Stem Cell Differentiation and Three-Dimensional Tissue Formation Attenuate Clonal Epigenetic Differences in Trichohyalin.</gtr:title><gtr:parentPublicationTitle>Stem cells and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5d422635ae66ce33dfe3534035548820"><gtr:id>5d422635ae66ce33dfe3534035548820</gtr:id><gtr:otherNames>Petrova A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1547-3287</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/66DC33D8-4487-405D-8E8F-CEE6059FC730"><gtr:id>66DC33D8-4487-405D-8E8F-CEE6059FC730</gtr:id><gtr:title>Generation of KCL034 clinical grade human embryonic stem cell line.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b307bcfeb7e0c589beee950062707ff7"><gtr:id>b307bcfeb7e0c589beee950062707ff7</gtr:id><gtr:otherNames>Devito L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3106DB8B-6188-4828-AAF0-35C1FE0EECD1"><gtr:id>3106DB8B-6188-4828-AAF0-35C1FE0EECD1</gtr:id><gtr:title>Generation of KCL036 research grade human embryonic stem cell line carrying a mutation in the HTT gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4a2afc7287a20b64627a082796f08d86"><gtr:id>4a2afc7287a20b64627a082796f08d86</gtr:id><gtr:otherNames>Jacquet L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/52D7F931-61C7-44D0-84D1-0DBAA469E060"><gtr:id>52D7F931-61C7-44D0-84D1-0DBAA469E060</gtr:id><gtr:title>Derivation of the King's College London human embryonic stem cell lines.</gtr:title><gtr:parentPublicationTitle>In vitro cellular &amp; developmental biology. Animal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/71cee36ebeeaa4bc610dcbf2411b4d7b"><gtr:id>71cee36ebeeaa4bc610dcbf2411b4d7b</gtr:id><gtr:otherNames>Stephenson EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1071-2690</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BE121353-51FC-4231-935A-78E28EC10FCC"><gtr:id>BE121353-51FC-4231-935A-78E28EC10FCC</gtr:id><gtr:title>Generation of KCL018 research grade human embryonic stem cell line carrying a mutation in the DMPK gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/05dab0f87d4725838fc83d9f2ff612b9"><gtr:id>05dab0f87d4725838fc83d9f2ff612b9</gtr:id><gtr:otherNames>Miere C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0E296257-D09A-4048-B74E-225DD9A9A0A5"><gtr:id>0E296257-D09A-4048-B74E-225DD9A9A0A5</gtr:id><gtr:title>Safety paradigm: genetic evaluation of therapeutic grade human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society, Interface</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3e2c772848d7675ee6ce668c80fc6d9c"><gtr:id>3e2c772848d7675ee6ce668c80fc6d9c</gtr:id><gtr:otherNames>Stephenson E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1742-5662</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/22AF6F78-44FA-4B61-9236-2177EDD15DBA"><gtr:id>22AF6F78-44FA-4B61-9236-2177EDD15DBA</gtr:id><gtr:title>3D In vitro model of a functional epidermal permeability barrier from human embryonic stem cells and induced pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5d422635ae66ce33dfe3534035548820"><gtr:id>5d422635ae66ce33dfe3534035548820</gtr:id><gtr:otherNames>Petrova A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-6711</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/212A82E9-7927-4732-91A8-049EF2FF5639"><gtr:id>212A82E9-7927-4732-91A8-049EF2FF5639</gtr:id><gtr:title>Derivation and propagation of human embryonic stem cell lines from frozen embryos in an animal product-free environment.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3e2c772848d7675ee6ce668c80fc6d9c"><gtr:id>3e2c772848d7675ee6ce668c80fc6d9c</gtr:id><gtr:otherNames>Stephenson E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5C4DAF91-670D-4D05-B898-FAE8394CDD74"><gtr:id>5C4DAF91-670D-4D05-B898-FAE8394CDD74</gtr:id><gtr:title>Stem cells in regenerative medicine: introduction.</gtr:title><gtr:parentPublicationTitle>British medical bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fab8c9425f975720e58fc9438c517385"><gtr:id>fab8c9425f975720e58fc9438c517385</gtr:id><gtr:otherNames>Ilic D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0007-1420</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F14F13D5-BCE7-4F1C-B168-E0A8B2FF3E11"><gtr:id>F14F13D5-BCE7-4F1C-B168-E0A8B2FF3E11</gtr:id><gtr:title>Generation of KCL026 research grade human embryonic stem cell line carrying a mutation in SMN1 gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5906459f71b6363885611cb5abc8de3a"><gtr:id>5906459f71b6363885611cb5abc8de3a</gtr:id><gtr:otherNames>Hewitson H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/440217D2-BA48-4A92-BBFA-DE68C2D37EF8"><gtr:id>440217D2-BA48-4A92-BBFA-DE68C2D37EF8</gtr:id><gtr:title>Industry highlights: Stem cell and regenerative medicine.</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fab8c9425f975720e58fc9438c517385"><gtr:id>fab8c9425f975720e58fc9438c517385</gtr:id><gtr:otherNames>Ilic D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D4F42E83-A8EF-4E2F-9E0F-9DB0018466BB"><gtr:id>D4F42E83-A8EF-4E2F-9E0F-9DB0018466BB</gtr:id><gtr:title>Ethics of mitochondrial gene replacement: from bench to bedside.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/da03624645d9044df6cdbb2072dcf62b"><gtr:id>da03624645d9044df6cdbb2072dcf62b</gtr:id><gtr:otherNames>Bredenoord AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0C5EF400-D69B-4682-9872-C8D9BF3A505C"><gtr:id>0C5EF400-D69B-4682-9872-C8D9BF3A505C</gtr:id><gtr:title>Generation of KCL021 research grade human embryonic stem cell line carrying a ?F508 mutation in the CFTR gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/05dab0f87d4725838fc83d9f2ff612b9"><gtr:id>05dab0f87d4725838fc83d9f2ff612b9</gtr:id><gtr:otherNames>Miere C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E96ED8B7-09A5-4231-AF5C-68FB66A30DA1"><gtr:id>E96ED8B7-09A5-4231-AF5C-68FB66A30DA1</gtr:id><gtr:title>Generation of KCL028 research grade human embryonic stem cell line carrying a mutation in the HTT gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4a2afc7287a20b64627a082796f08d86"><gtr:id>4a2afc7287a20b64627a082796f08d86</gtr:id><gtr:otherNames>Jacquet L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5FC1309D-B96F-4264-B35D-57F66ABB94AA"><gtr:id>5FC1309D-B96F-4264-B35D-57F66ABB94AA</gtr:id><gtr:title>Strategy for the creation of clinical grade hESC line banks that HLA-match a target population.</gtr:title><gtr:parentPublicationTitle>EMBO molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4a2afc7287a20b64627a082796f08d86"><gtr:id>4a2afc7287a20b64627a082796f08d86</gtr:id><gtr:otherNames>Jacquet L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1757-4676</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/85DFDE15-D86D-471D-A4C5-E90FB469591A"><gtr:id>85DFDE15-D86D-471D-A4C5-E90FB469591A</gtr:id><gtr:title>Concise Review: Human Embryonic Stem Cells-What Have We Done? What Are We Doing? Where Are We Going?</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fab8c9425f975720e58fc9438c517385"><gtr:id>fab8c9425f975720e58fc9438c517385</gtr:id><gtr:otherNames>Ilic D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FC6A37EA-08BC-42AE-A1FB-2125D3BB4A51"><gtr:id>FC6A37EA-08BC-42AE-A1FB-2125D3BB4A51</gtr:id><gtr:title>Generation of KCL025 research grade human embryonic stem cell line carrying a mutation in NF1 gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5906459f71b6363885611cb5abc8de3a"><gtr:id>5906459f71b6363885611cb5abc8de3a</gtr:id><gtr:otherNames>Hewitson H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A9619CA6-2091-4108-AF46-342C2CA1CECF"><gtr:id>A9619CA6-2091-4108-AF46-342C2CA1CECF</gtr:id><gtr:title>Cost-effective master cell bank validation of multiple clinical-grade human pluripotent stem cell lines from a single donor.</gtr:title><gtr:parentPublicationTitle>Stem cells translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b307bcfeb7e0c589beee950062707ff7"><gtr:id>b307bcfeb7e0c589beee950062707ff7</gtr:id><gtr:otherNames>Devito L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2157-6564</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4CF2E05C-FE02-428A-914E-C530034ECB49"><gtr:id>4CF2E05C-FE02-428A-914E-C530034ECB49</gtr:id><gtr:title>Generation of KCL017 research grade human embryonic stem cell line carrying a mutation in VHL gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5906459f71b6363885611cb5abc8de3a"><gtr:id>5906459f71b6363885611cb5abc8de3a</gtr:id><gtr:otherNames>Hewitson H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701172</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>